PharmaShots | Incisive News in 3 Shots

Subscribe Now

Brii Bio

Brii Bio’s Amubarvimab + Romlusevimab Receives NMPA’s Approval for the Treatment of COVID-19

Brii Bio’s Amubarvimab + Romlusevimab Receives NMPA’s Approval for the Treatment of COVID-19

December 9, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us